Advisornet Financial’s United Therapeutics UTHR Stock Holding History

Advisornet Financial’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$593	Hold	1	–	–	﹤0.01%	2077
2025 Q4	$487	Sell	1 -1	-50%	-$466	﹤0.01%	2095
2025 Q3	$838	Buy	+2	New	+$673	﹤0.01%	1991
2025 Q2	–	Sell	-1	Closed	-$308	–	2374
2025 Q1	$308	Hold	1	–	–	﹤0.01%	2038
2024 Q4	$353	Buy	+1	New	+$368	﹤0.01%	1828
2024 Q1	–	Sell	-14	Closed	-$3.08K	–	2504
2023 Q4	$3.08K	Sell	14 -1	-7%	-$230	﹤0.01%	1605
2023 Q3	$3.39K	Buy	15 +1	+7%	+$230	﹤0.01%	1517
2023 Q2	$3.09K	Buy	+14	New	+$3.1K	﹤0.01%	1621
2023 Q1	–	Sell	-13	Closed	-$3.62K	–	2491
2022 Q4	$3.62K	Buy	+13	New	+$3.28K	﹤0.01%	1543

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Advisornet Financial's UTHR Position: Q1 2026 in Review

Advisornet Financial held its United Therapeutics (UTHR) position steady in Q1 2026 at 1 share worth $593. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Advisornet Financial first reported a position in UTHR in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.62K in Q4 2022. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

Advisornet Financial held 1 share of United Therapeutics worth $593 as of Q1 2026.
Advisornet Financial left its United Therapeutics share count unchanged in Q1 2026.
United Therapeutics made up ﹤0.01% of Advisornet Financial's portfolio in Q1 2026, its #2077 holding.
Advisornet Financial first reported a position in United Therapeutics in Q4 2022 and has held it in 9 quarters since.
Advisornet Financial's United Therapeutics position peaked at $3.62K in Q4 2022.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.